Viridian Therapeutics, Inc.
VRDN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $170 | $117 | $116 | $100 |
| Short-Term Investments | $321 | $446 | $520 | $618 |
| Receivables | $70 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $11 | $15 | $21 | $21 |
| Total Curr. Assets | $572 | $579 | $657 | $738 |
| Property Plant & Equip (Net) | $4 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $1 | $0 | $1 |
| Total NC Assets | $5 | $4 | $4 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $577 | $582 | $661 | $742 |
| Liabilities | – | – | – | – |
| Payables | $10 | $9 | $4 | $2 |
| Short-Term Debt | $1 | $9 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $40 | $35 | $29 | $45 |
| Total Curr. Liab. | $51 | $53 | $34 | $48 |
| LT Debt | $23 | $12 | $21 | $21 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $2 | $2 | $2 |
| Total NC Liab. | $23 | $15 | $23 | $23 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $1 | $1 | $1 |
| Total Liabilities | $74 | $67 | $57 | $71 |
| Equity | – | – | – | – |
| Pref Stock | $189 | $189 | $189 | $189 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$1,218 | -$1,184 | -$1,083 | -$996 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $1,531 | $1,509 | $1,497 | $1,478 |
| Total Equity | $503 | $515 | $604 | $672 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $577 | $582 | $661 | $742 |
| Net Debt | -$146 | -$96 | -$95 | -$78 |